Nurix Therapeutics Presents Positive Results from the Ongoing Clinical[...]
08/25/2021 | Press release | Distributed by Public on 08/25/2021 05:11
Please select the service you want to use:
Smartlinks | ERYTECH Pharma SA | News | Health | Finance | Markets and Exchanges | Company News | Public Companies | Biotechnology and Medical Research Companies | London Stock Exchange (LSE) | Börse Frankfurt | Börse Stuttgart | NYSE American | NYSE ARCA Equities | Turquoise | Euronext Paris | Nasdaq Global Select Market | BZX Exchange | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | Börse Berlin Equiduct Trading | SIGMA X MTF | NYSE Chicago | Euronext Block MTF
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact